Behavioral changes produced in rats by developmental exposure to flumazenil, a benzodiazepine receptor antagonist

Prog Neuropsychopharmacol Biol Psychiatry. 1993 Jan;17(1):151-9. doi: 10.1016/0278-5846(93)90039-u.

Abstract

1. Prolonged administration of a benzodiazepine receptor antagonist, such as flumazenil (given to the mother at a dose of 3 mg/kg s.c. from day 14 to day 20 of gestation), produced subtle behavioral changes in rat pups. 2. Flumazenil treatment decreased the rate of ultrasonic vocalization in 15-day old male pups removed from their nest. 3. No significant changes in the locomotor activity of the flumazenil-treated group with respect to controls was found at the end of the second and fourth postnatal week. 4. These results suggest that late prenatal exposure to flumazenil induces in rat offspring behavioral changes characterized by decreased emotional responsiveness to environmental challenges.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Behavior, Animal / drug effects*
  • Female
  • Flumazenil / pharmacology*
  • GABA-A Receptor Antagonists*
  • Male
  • Motor Activity / drug effects
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Rats
  • Rats, Sprague-Dawley
  • Vocalization, Animal / drug effects

Substances

  • GABA-A Receptor Antagonists
  • Flumazenil